...
机译:子宫内膜子宫内膜癌症患者的造成特异性死亡率2型糖尿病使用二甲双胍或其他类型的抗糖尿病药物
Department of Obstetrics and Gynecology PEDEGO Research Unit Medical Research Center Oulu;
Children Adolescents and Families Unit Department of Welfare National Institute for Health and;
Children Adolescents and Families Unit Department of Welfare National Institute for Health and;
Service System Research Unit National Institute for Health and Welfare;
Centre for Research Methods Department of Social Research University of Helsinki;
Science Center Tampere University Hospital;
Department of Pathology Medical Research Center Oulu University of Oulu and University Hospital;
Department of Obstetrics and Gynecology PEDEGO Research Unit Medical Research Center Oulu;
Department of Obstetrics and Gynecology PEDEGO Research Unit Medical Research Center Oulu;
Research Unit of Mathematical Sciences University of Oulu;
EC; Endometrial cancer; Metformin; Antidiabetic medication; Cause-specific mortality; Endometrioid; Retrospective cohort study;
机译:子宫内膜子宫内膜癌症患者的造成特异性死亡率2型糖尿病使用二甲双胍或其他类型的抗糖尿病药物
机译:糖尿病患者患有2型糖尿病患者非胚胎子宫内膜癌的抗糖尿病药物和预后
机译:预先存在的2型糖尿病的影响和抗糖尿病药物对患有乳腺癌的医疗补助保险妇女的所有原因和造成特异性死亡率
机译:None
机译:药品补充保险女性的全因和造成特异性死亡率,具有患有乳腺癌的预先存在的2型糖尿病:与纽约国家医疗补助联系的流行病学分析和癌症注册表数据
机译:二甲双胍和其他形式的抗糖尿病药物或他汀类药物对2型糖尿病女性卵巢癌的预后:一项回顾性队列研究
机译:系统综述及荟萃分析二甲双胍治疗对子宫内膜癌妇女总体死亡率的影响和2型糖尿病